MANAGEMENT

We are governed and supervised by a five-person board of directors. Our day-to-day operations are managed by the Company’s officers.


Board of Directors

The Company’s Board of Directors consists of the following members:

Frank Gerardi
Chairman
Robert C. Hackney
Director
John Fanaras                                         
Director
Richard P. Tambone
Director
Tipton Shonkwiler
Director
   

NOTE:  For Full bio on Board of Director Members, see Appendix


Corporate Management

Frank Gerardi
Interim Chief Executive Officer
Richard P. Tambone
Chief Financial Officer
John Fanaras
Chief Operating Officer
Robert C. Hackney
Secretary

Scientific Advisor

David J. Vaughan acts as an advisor to the Company. Dr. Vaughan holds a Ph.D. in Clinical Pathology and Biochemistry from the University of Toronto as well as an M.Sc. in Biochemistry and a B. Sc. In Chemistry from Memorial University of Newfoundland. Dr. David Vaughan is currently active as an independent consultant to the Pharmaceutical Industry with significant clinical / preclinical development and regulatory expertise in the Anti-infectives, Pain, CNS, and Gastrointestinal Disease areas. Dr. Vaughan has guided and successfully completed preclinical development programs for several biotechnology companies resulting in multiple IND and CTA approvals. Dr. Vaughan has a lengthy Curriculum Vitae and has worked in the pharmaceutical industry for over thirty years.